Genomic Profiling in Recommending Treatment for Patients With Metastatic Solid Tumors (NCT02215928)
Tumor Genomic Profiling: A Personalized Medicine Approach
🩺 Plain-English Summary (8th-Grade Level)
This research trial studies using genomic profiling to recommend anticancer treatment to patients with cancer that has spread beyond the original site of the tumor (metastatic cancer). Genomic profiling studies the deoxyribonucleic acid (DNA) of a tumor to detect genetic changes or abnormalities. This information can then be used to recommend treatments that may be more likely to result in a beneficial response. It is not yet known whether genomic profiling will detect abnormalities that can be used to make treatment recommendations and whether treatment based on genomic profiling is more effective than standard treatment.
Who can join: Review the eligibility criteria below.
Location: Stanford University — Palo Alto, California
Age range: 18 Years
🧪 Interventions in This Study
- mutation analysis (GENETIC)
- cytology specimen collection procedure (OTHER)
- laboratory biomarker analysis (OTHER)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stanford University — Palo Alto, California
📞 Contact the Study Coordinator
Phone: (650) 724-9948
Email: rlaquind@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Unspecified Adult Solid Tumor, Protocol Specific
- RNR Inhibitor COH29 in Treating Patients With Solid Tumors That Are Refractory to Standard Therapy or For Which No Standard Therapy Exists — Duarte, California
- Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors — Winston-Salem, North Carolina
- Collecting Tissue Samples From Patients With Cancer Undergoing Radiation Therapy and Healthy Participants — Dallas, Texas
Explore by condition: All Unspecified Adult Solid Tumor, Protocol Specific clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.